1. Home
  2. GNLX vs MBINN Comparison

GNLX vs MBINN Comparison

Compare GNLX & MBINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • MBINN
  • Stock Information
  • Founded
  • GNLX 2001
  • MBINN N/A
  • Country
  • GNLX United States
  • MBINN United States
  • Employees
  • GNLX N/A
  • MBINN 663
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • MBINN Major Banks
  • Sector
  • GNLX Health Care
  • MBINN Finance
  • Exchange
  • GNLX Nasdaq
  • MBINN Nasdaq
  • Market Cap
  • GNLX 112.8M
  • MBINN N/A
  • IPO Year
  • GNLX 2023
  • MBINN N/A
  • Fundamental
  • Price
  • GNLX $3.09
  • MBINN $19.79
  • Analyst Decision
  • GNLX Strong Buy
  • MBINN
  • Analyst Count
  • GNLX 4
  • MBINN 0
  • Target Price
  • GNLX $17.75
  • MBINN N/A
  • AVG Volume (30 Days)
  • GNLX 137.5K
  • MBINN N/A
  • Earning Date
  • GNLX 08-13-2025
  • MBINN N/A
  • Dividend Yield
  • GNLX N/A
  • MBINN N/A
  • EPS Growth
  • GNLX N/A
  • MBINN N/A
  • EPS
  • GNLX N/A
  • MBINN N/A
  • Revenue
  • GNLX N/A
  • MBINN N/A
  • Revenue This Year
  • GNLX N/A
  • MBINN N/A
  • Revenue Next Year
  • GNLX N/A
  • MBINN N/A
  • P/E Ratio
  • GNLX N/A
  • MBINN N/A
  • Revenue Growth
  • GNLX N/A
  • MBINN N/A
  • 52 Week Low
  • GNLX $1.60
  • MBINN N/A
  • 52 Week High
  • GNLX $5.89
  • MBINN N/A
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 56.10
  • MBINN 50.08
  • Support Level
  • GNLX $2.75
  • MBINN $19.28
  • Resistance Level
  • GNLX $3.17
  • MBINN $19.99
  • Average True Range (ATR)
  • GNLX 0.24
  • MBINN 0.30
  • MACD
  • GNLX -0.00
  • MBINN -0.02
  • Stochastic Oscillator
  • GNLX 56.94
  • MBINN 63.75

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About MBINN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: